HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION
Clinical trials for HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION trials appear
Sign up with your email to follow new studies for HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Kids' pneumonia shot tested alongside standard vaccines
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of a new pneumococcal vaccine (SP0202) in healthy infants and toddlers. The goal was to see how well it worked and how safe it was when given at the same time as other standard childhood vaccines. Researchers enrolled 852 children …
Matched conditions: HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
One shot, six protections: new combo vaccine for infants shows promise
⭐️ VACCINE ⭐️ CompletedThis study tested a new combination vaccine (Shan6™) designed to protect infants against six serious diseases: diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio. It involved 460 healthy infants and toddlers in Thailand to see if the new vaccine worked as well as th…
Matched conditions: HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Vaccine safety check: tracking infant reactions in routine shots
⭐️ VACCINE ⭐️ CompletedThis study monitored the safety of the Hexaxim vaccine, which protects against six diseases including hepatitis B and Hib, after it was given to infants as part of routine care in South Korea. Researchers tracked over 700 infants for about 5-6 weeks after vaccination to record an…
Matched conditions: HAEMOPHILUS INFLUENZAE TYPE B IMMUNISATION
Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:37 UTC